Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform


Out of Business LATEST DEAL TYPE

Developer of microbiome-derived therapeutics platform intended to promote a lifetime of good health. The company's microbiome-derived therapeutics platform focuses on preventing and treating diseases through microbiome-based treatments in infancy and early childhood, enabling physicians to protect babies born via C-section from the future onset of a variety of serious conditions.

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 501 Boylston Street
  • Suite 6102
  • Boston, MA 02116
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Commense’s full profile, request a free trial.

Commense Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Dec-2018 Completed Out of Business
1. Buyout/LBO Completed Startup
To view this company’s complete deal history including valuation and funding, request access »